Figure 2:
Relative survival by protocol restricted to patients remaining progression-free after 3 years. For several scenarios (A, B, C), normal-like values are reached progressively earlier with transition from TT2- to TT2+ to TT3A to TT3B.
Relative survival by protocol restricted to patients remaining progression-free after 3 years. For several scenarios (A, B, C), normal-like values are reached progressively earlier with transition from TT2- to TT2+ to TT3A to TT3B.
